Hypoxia	S-DISEASE
enhances	O
the	O
expression	O
of	O
prostate	O
-	O
specific	O
antigen	O
by	O
modifying	O
the	O
quantity	O
and	O
catalytic	O
activity	O
of	O
Jumonji	O
C	O
domain	O
-	O
containing	O
histone	O
demethylases	O
.	O


Oxygen	O
concentration	O
in	O
prostate	B-DISEASE
cancer	E-DISEASE
tissue	O
is	O
significantly	O
low	O
,	O
i	O
.	O
e	O
.	O
~	O
0	O
.	O
3	O
%	O
O2	O
.	O


This	O
study	O
showed	O
that	O
pathological	O
hypoxia	S-DISEASE
(	O
<	O
0	O
.	O
5	O
%	O
O2	O
)	O
increased	O
the	O
expression	O
of	O
androgen	O
receptor	O
(	O
AR	O
)	O
target	O
genes	O
such	O
as	O
prostate	O
-	O
specific	O
antigen	O
(	O
PSA	O
)	O
and	O
kallikrein	O
-	O
related	O
peptidase	O
2	O
in	O
LNCaP	O
human	O
prostate	O
cancer	O
cells	O
by	O
modifying	O
the	O
quantity	O
and	O
activity	O
of	O
related	O
Jumonji	O
C	O
domain	O
-	O
containing	O
histone	O
demethylases	O
(	O
JMJDs	O
)	O
.	O


Under	O
pathological	O
hypoxia	S-DISEASE
,	O
the	O
catalytic	O
activities	O
of	O
JMJD2A	O
,	O
JMJD2C	O
and	O
Jumonji	O
/	O
ARID	O
domain	O
-	O
containing	O
protein	O
1B	O
(	O
JARID1B	O
)	O
were	O
blocked	O
due	O
to	O
the	O
lack	O
of	O
their	O
substrate	O
,	O
i	O
.	O
e	O
.	O
oxygen	O
.	O


Chromatin	O
immunoprecipitation	O
analyses	O
showed	O
that	O
hypoxia	S-DISEASE
increased	O
the	O
appearance	O
of	O
H3K9me3	O
and	O
H3K4me3	O
,	O
substrates	O
of	O
JMJD2s	O
and	O
JARID1B	O
,	O
respectively	O
,	O
in	O
the	O
PSA	O
enhancer	O
.	O


In	O
contrast	O
,	O
JMJD1A	O
,	O
which	O
demethylates	O
both	O
H3K9me2	O
and	O
H3K9me1	O
,	O
maintained	O
its	O
catalytic	O
activity	O
even	O
under	O
severe	O
hypoxia	S-DISEASE
.	O


Furthermore	O
,	O
hypoxia	S-DISEASE
increased	O
the	O
expression	O
of	O
JMJD1A	O
.	O
Hypoxia	S-DISEASE
and	O
androgen	O
additively	O
increased	O
the	O
recruitment	O
of	O
JMJD1A	O
and	O
p300	O
on	O
the	O
enhancer	O
region	O
of	O
PSA	O
through	O
interaction	O
with	O
the	O
hypoxia	O
-	O
inducible	O
factor	O
-	O
1alpha	O
and	O
AR	O
,	O
both	O
of	O
which	O
bind	O
the	O
PSA	O
enhancer	O
.	O


Thus	O
,	O
hypoxia	S-DISEASE
enhanced	O
the	O
demethylation	O
of	O
H3K9me2	O
and	O
H3K9me1	O
,	O
leading	O
to	O
provide	O
unmethylated	O
H3K9	O
residues	O
that	O
are	O
substrates	O
for	O
histone	O
acetyltransferase	O
,	O
p300	O
.	O


Consequently	O
,	O
hypoxia	S-DISEASE
increased	O
the	O
acetylation	O
of	O
histones	O
of	O
the	O
PSA	O
enhancer	O
,	O
which	O
facilitates	O
its	O
transcription	O
.	O
